Nadunolimab's additional potential in mitigating neuropathy demonstrated by data from Cantargia's CESTAFOUR and CAPAFOUR ...
Neuropathy, or nerve damage, can develop in anyone, but some people are at higher risk due to various factors. Josiah ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results